Delivery Order SPE2DB24D1007-SPE2DB25FBZHR

Award Date 11/18/24
Potential Completion Date 11/19/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,009.84, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract, valued at $1,286.44, is a Firm Fixed Price Delivery Order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products...
This federal contract award, valued at $1,296.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a performance period ending on May 1, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award, valued at $1,371.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a completion date of November 15, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,441.81 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award, valued at $7,592.88, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4560832621 - NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of May 5, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award, valued at $1,640.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for healthcare purposes. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 22, 2025. The contract does not have a set-aside designation,...
This federal contract award, valued at $2,605.50, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a completion date of October 25, 2024. This award is a part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $3,242.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used in healthcare settings. The contract has an ultimate completion date of March 26, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen...
This federal contract award, valued at $1,166.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of March 14, 2025. The contract covers the provision of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to support military healthcare programs. AmerisourceBergen holds a significant...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB25FBZHR
    Delivery Order

This federal contract award, valued at $1,253.71, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of November 19, 2024 and is a Firm Fixed Price delivery order.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:04 PM